Alcohol Consumption and Tryptophan Metabolism Among People with HIV Prior to Antiretroviral Therapy Initiation: The Uganda ARCH Cohort Study

dc.contributor.authorPierre, Frantz
dc.contributor.authorForman, Leah S.
dc.contributor.authorWinter, Michael
dc.contributor.authorCheng, Debbie
dc.contributor.authorNgabirano, Christine
dc.contributor.authorEmenyonu, Nneka
dc.contributor.authorHunt, Peter W.
dc.contributor.authorHuang, Yong
dc.contributor.authorMuyindike, Winnie
dc.contributor.authorSamet, Jeffrey
dc.contributor.authorHahn, Judith A.
dc.contributor.authorSo-Armah, Kaku
dc.date.accessioned2024-04-25T12:59:59Z
dc.date.available2024-04-25T12:59:59Z
dc.date.issued2022
dc.description.abstractAims: Alcohol is hypothesized to have effects on the kynurenine pathway of tryptophan catabolism, a potential mechanism for alcohol-induced depression and aggression. A biomarker of this pathway, the plasma kynurenine to tryptophan ratio (K/T ratio), has been associated with HIV progression, mortality and depression. Our aim was to assess whether hazardous alcohol consumption is associated higher K/T ratio among people with HIV. Methods: Participants were a subset of the Uganda Alcohol Research Collaboration on HIV/AIDS Cohort. Alcohol consumption was categorized (abstinent, moderate and hazardous alcohol use) using the Alcohol Use Disorders Identification Test—Consumption and phosphatidylethanol (PEth). K/T ratio was the primary outcome. We used linear regression adjusted for age, sex, FIB-4, hepatitis Bsurface antigen, log (HIV viral load) to estimate the association between alcohol consumption and K/T ratio. Results: Compared to abstinent participants, hazardous drinkers and moderate drinkers had higher K/T ratio but these differences did not reach statistical significance. Conclusions: Our results suggest that hazardous alcohol consumption, in the context of untreated HIV infection, may not significantly alter kynurenine to tryptophan ratio as a measure of activity of the kynurenine pathway of tryptophan metabolismen_US
dc.description.sponsorshipNational Institutes of Health: R01 AA018631, U01AA020776, K24AA022586, U24AA020778, U24AA020779 and K01HL13414704en_US
dc.identifier.citationPierre, F., Forman, L. S., Winter, M., Cheng, D., Ngabirano, C., Emenyonu, N., ... & So-Armah, K. (2022). Alcohol consumption and tryptophan metabolism among people with HIV prior to antiretroviral therapy initiation: The Uganda ARCH Cohort Study. Alcohol and Alcoholism, 57(2), 219-225.en_US
dc.identifier.urihttp://ir.must.ac.ug/handle/123456789/3596
dc.language.isoen_USen_US
dc.publisherAlcohol and Alcoholismen_US
dc.subjectAlcohol Consumptionen_US
dc.subjectTryptophan Metabolismen_US
dc.subjectHIVen_US
dc.subjectAntiretroviral therapyen_US
dc.subjectUgandaen_US
dc.titleAlcohol Consumption and Tryptophan Metabolism Among People with HIV Prior to Antiretroviral Therapy Initiation: The Uganda ARCH Cohort Studyen_US
dc.typeArticleen_US

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Alcohol Consumption and Tryptophan Metabolism Among People with HIV Prior to Antiretroviral Therapy Initiation-the Uganda ARCH Cohort Study.pdf
Size:
208.79 KB
Format:
Adobe Portable Document Format
Description:
Main Article

License bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: